BECN1 and in situ carcinoma: A significant increase in Beclin-1 concentrations was observed in the kidneys of CIS-treated Gal-3 wild-type mice compared to Gal-3 wild-type sham control mice, showing statistical significance (p < 0.01) (Figure 10C).